Skip to main content

Table 1 Frequency of immunohistochemical detection of CTAs and NY-BR-1 with the corresponding mAbs in breast cancer

From: Cancer testis antigens and NY-BR-1 expression in primary breast cancer: prognostic and therapeutic implications

  n %
MAGE-A1 MA 454 21 (140) 15
mAb M3H67 17 (132) 12,9
mAb 57B 6 (133) 4,5
NY-ESO-1 E978 21 (140) 15
GAGE #26 17 (133) 12,8
MAGE-A 6C1 7 (141) 5
NY-BR-1 #5 61 (131) 46,6
  1. n=number of cases with antigen positivity, in parenthesis total number with successful TMA mapping for each antigen.